Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-20 10:05 am Sale | 2025-06-30 | 13G | OptiNose, Inc. OPTN | Armistice Capital, LLC | 754,867 0.290% | -28,437,314 (-97.41%) | Filing History |
| 2025-08-15 12:32 pm Purchase | 2025-06-30 | 13G | KINETA INC KANT | Armistice Capital, LLC | 1,823,138 3.640% | 456,322 (+33.39%) | Filing History |
| 2025-08-15 12:30 pm Purchase | 2025-06-30 | 13G | Rockwell Medical, Inc. RMTI | Armistice Capital, LLC | 8,876,000 9.960% | 8,876,000 (New Position) | Filing History |
| 2025-08-15 12:29 pm Purchase | 2025-06-30 | 13G | Rekor Systems, Inc. REKR | Armistice Capital, LLC | 2,473,801 5.180% | 2,473,801 (New Position) | Filing History |
| 2025-08-15 12:29 pm Purchase | 2025-06-30 | 13G | Rani Therapeutics Holdings, Inc. RANI | Armistice Capital, LLC | 6,260,000 9.910% | 6,260,000 (New Position) | Filing History |
| 2025-08-15 12:28 pm Purchase | 2025-06-30 | 13G | ProMIS Neurosciences, Inc. PMN | Armistice Capital, LLC | 4,812,000 8.580% | 4,812,000 (New Position) | Filing History |
| 2025-08-15 12:27 pm Purchase | 2025-06-30 | 13G | PDS Biotechnology Corporation PDSB | Armistice Capital, LLC | 2,812,000 5.670% | 2,812,000 (New Position) | Filing History |
| 2025-08-15 12:26 pm Purchase | 2025-06-30 | 13G | DANIMER SCIENTIFIC INC DNMRQ | Armistice Capital, LLC | 6,200,000 7.140% | 6,200,000 (New Position) | Filing History |
| 2025-08-15 12:26 pm Purchase | 2025-06-30 | 13G | Cyclo Therapeutics, Inc. CYTH | Armistice Capital, LLC | 16,150,000 9.940% | 16,150,000 (New Position) | Filing History |
| 2025-08-15 12:25 pm Sale | 2025-06-30 | 13G | BIO-key International, Inc. BKYI | Armistice Capital, LLC | 359,703 4.990% | -236,698 (-39.69%) | Filing History |
| 2025-08-15 12:24 pm Purchase | 2025-06-30 | 13G | BriaCell Therapeutics Corp. BCTX | Armistice Capital, LLC | 33,600 8.310% | 33,600 (New Position) | Filing History |
| 2025-08-14 9:43 pm Unchanged | 2025-03-31 | 13G | VolitionRx Limited VNRX | Armistice Capital, LLC | 9,804,352 9.990% | 0 (Unchanged) | Filing History |
| 2025-08-14 9:42 pm Purchase | 2025-06-30 | 13G | Kura Oncology, Inc. KURA | Armistice Capital, LLC | 4,735,464 5.960% | 4,735,464 (New Position) | Filing History |
| 2025-08-14 9:41 pm Purchase | 2025-03-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Armistice Capital, LLC | 9,235,571 9.990% | 8,312,014 (+900.00%) | Filing History |
| 2025-08-14 9:40 pm Purchase | 2025-06-30 | 13G | Assembly Biosciences, Inc. ASMB | Armistice Capital, LLC | 289,876 9.990% | 289,876 (New Position) | Filing History |
| 2025-08-14 9:40 pm Purchase | 2025-06-30 | 13G | Scilex Holding Company SCLX | Armistice Capital, LLC | 4,800,000 8.650% | 4,800,000 (New Position) | Filing History |
| 2025-08-14 9:40 pm Purchase | 2025-06-30 | 13G | Acurx Pharmaceuticals, Inc. ACXP | Armistice Capital, LLC | 1,287,337 9.990% | 1,287,337 (New Position) | Filing History |
| 2025-08-14 9:38 pm Unchanged | 2025-06-30 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Armistice Capital, LLC | 5,096,251 11.430% | 0 (Unchanged) | Filing History |
| 2025-08-14 9:37 pm Purchase | 2025-06-30 | 13G | Ontrak, Inc. OTRK | Armistice Capital, LLC | 400,000 3.220% | 400,000 (New Position) | Filing History |
| 2025-08-14 9:37 pm Purchase | 2025-06-30 | 13G | Alto Neuroscience, Inc. ANRO | Armistice Capital, LLC | 1,996,000 7.050% | 1,996,000 (New Position) | Filing History |